We are grateful to GEMMA Biotherapeutics and James M. Wilson, MD, PhD for continuing to work on GM1 gangliosidosis.
James M. Wilson, MD, PhD founded two biotechs, GEMMA Biotherapeutics and Franklin Biolabs, to prove that gene therapies could be good business. “I think what we’re seeing now is more than a correction, and I’ll coin the term ‘irrational pessimism,’” Wilson said at #STATBreakthrough.